Oruka Therapeutics Insider Trades
NASDAQ: ORKAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 75 · $26.42M
- Shares bought / sold
- 0 / 278.86K
- Net activity
- Net selling $26.4 million
Oruka Therapeutics insider activity
Over the last 12 months, Oruka Therapeutics insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 75 sales. Insiders bought $0 and sold $26.4 million worth of stock, for net insider selling of $26.4 million. The largest seller was Klein Lawrence Otto, with $11.6 million in reported sales.
The most recent filing shows Quinlan Paul T (General Counsel) reporting a transaction in 9,000 shares at $7.80 on Nov 20, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ORKA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ORKA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 200 | $19.32K | Form 4 |
| Nov 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 2,500 | $239.99K | Form 4 |
| Nov 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 3,000 | $284.32K | Form 4 |
| Nov 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 3,300 | $310.36K | Form 4 |
| Nov 20, 2026 | Quinlan Paul TGeneral Counsel | Option exercise | 9,000 | $70.20K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Sale | 500 | $52.93K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Sale | 200 | $20.67K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Sale | 300 | $30.74K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Sale | 1,900 | $192.90K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Sale | 1,500 | $150.72K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Sale | 2,600 | $258.74K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $27.30K | Form 4 |
| Nov 16, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $23.94K | Form 4 |
| Nov 12, 2026 | BALL KRISTINE MDirector | Sale | 200 | $21.40K | Form 4 |
| Nov 12, 2026 | BALL KRISTINE MDirector | Sale | 2,500 | $265.13K | Form 4 |
| Nov 12, 2026 | BALL KRISTINE MDirector | Sale | 10,765 | $1.13M | Form 4 |
| Nov 12, 2026 | BALL KRISTINE MDirector | Sale | 2,039 | $212.39K | Form 4 |
| Nov 12, 2026 | BALL KRISTINE MDirector | Sale | 1,300 | $134.02K | Form 4 |
| Nov 12, 2026 | BALL KRISTINE MDirector | Sale | 1,196 | $122.11K | Form 4 |
| Nov 12, 2026 | BALL KRISTINE MDirector | Option exercise | 18,000 | $123.12K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 100 | $10.70K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 958 | $101.72K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 6,842 | $720.33K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 799 | $83.30K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 801 | $82.63K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 500 | $50.99K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Option exercise | 1,458 | $50.14K | Form 4 |
| Nov 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Option exercise | 8,542 | $106.78K | Form 4 |
| Nov 2, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 300 | $29.52K | Form 4 |
| Nov 2, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 756 | $73.68K | Form 4 |
| Nov 2, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 2,442 | $236.15K | Form 4 |
| Nov 2, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 15,036 | $1.44M | Form 4 |
| Nov 2, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 6,466 | $612.79K | Form 4 |
| Nov 2, 2026 | Klein Lawrence OttoChief Executive Officer | Option exercise | 25,000 | $195.00K | Form 4 |
| Oct 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 3,000 | $238.47K | Form 4 |
| Oct 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 4,100 | $323.04K | Form 4 |
| Oct 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 1,000 | $77.20K | Form 4 |
| Oct 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 500 | $38.06K | Form 4 |
| Oct 20, 2026 | Quinlan Paul TGeneral Counsel | Sale | 400 | $29.96K | Form 4 |
| Oct 20, 2026 | Quinlan Paul TGeneral Counsel | Option exercise | 9,000 | $70.20K | Form 4 |
| Oct 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 200 | $15.54K | Form 4 |
| Oct 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 700 | $53.67K | Form 4 |
| Oct 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 1,400 | $105.68K | Form 4 |
| Oct 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 1,847 | $137.96K | Form 4 |
| Oct 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 2,853 | $210.81K | Form 4 |
| Oct 15, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $27.30K | Form 4 |
| Oct 15, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $23.94K | Form 4 |
| Oct 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 200 | $16.57K | Form 4 |
| Oct 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 1,958 | $160.27K | Form 4 |
| Oct 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 2,100 | $169.60K | Form 4 |
| Oct 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 5,741 | $459.45K | Form 4 |
| Oct 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Option exercise | 1,458 | $50.14K | Form 4 |
| Oct 12, 2026 | Agarwal ArjunSenior Vice President, Finance | Option exercise | 8,541 | $106.76K | Form 4 |
| Oct 1, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 200 | $16.96K | Form 4 |
| Oct 1, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 8,554 | $718.75K | Form 4 |
| Oct 1, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 16,246 | $1.35M | Form 4 |
| Oct 1, 2026 | Klein Lawrence OttoChief Executive Officer | Option exercise | 25,000 | $195.00K | Form 4 |
| Sep 21, 2026 | Quinlan Paul TGeneral Counsel | Sale | 2,667 | $254.20K | Form 4 |
| Sep 21, 2026 | Quinlan Paul TGeneral Counsel | Sale | 601 | $56.76K | Form 4 |
| Sep 21, 2026 | Quinlan Paul TGeneral Counsel | Sale | 3,832 | $357.59K | Form 4 |
| Sep 21, 2026 | Quinlan Paul TGeneral Counsel | Sale | 2,900 | $267.87K | Form 4 |
| Sep 21, 2026 | Quinlan Paul TGeneral Counsel | Option exercise | 10,000 | $78.00K | Form 4 |
| Sep 21, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 533 | $51.03K | Form 4 |
| Sep 15, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 2,452 | $234.68K | Form 4 |
| Sep 15, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 560 | $53.60K | Form 4 |
| Sep 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 947 | $90.64K | Form 4 |
| Sep 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 100 | $9.42K | Form 4 |
| Sep 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 1,366 | $127.02K | Form 4 |
| Sep 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 3,150 | $289.89K | Form 4 |
| Sep 15, 2026 | Goncalves JoanaChief Medical Officer | Sale | 2,384 | $217.17K | Form 4 |
| Sep 15, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $27.30K | Form 4 |
| Sep 15, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $23.94K | Form 4 |
| Sep 15, 2026 | Sandler Laura LeeChief Operating Officer | Sale | 906 | $86.71K | Form 4 |
| Sep 15, 2026 | Quinlan Paul TGeneral Counsel | Sale | 1,039 | $99.44K | Form 4 |
| Sep 11, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 200 | $18.80K | Form 4 |
| Sep 11, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 2,208 | $205.92K | Form 4 |
| Sep 11, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 4,051 | $374.37K | Form 4 |
| Sep 11, 2026 | Agarwal ArjunSenior Vice President, Finance | Sale | 3,000 | $273.32K | Form 4 |
| Sep 11, 2026 | Agarwal ArjunSenior Vice President, Finance | Option exercise | 1,459 | $50.18K | Form 4 |
| Sep 11, 2026 | Agarwal ArjunSenior Vice President, Finance | Option exercise | 8,000 | $100.00K | Form 4 |
| Sep 1, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 4,800 | $443.69K | Form 4 |
| Sep 1, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 63,596 | $5.84M | Form 4 |
| Sep 1, 2026 | Klein Lawrence OttoChief Executive Officer | Sale | 6,604 | $599.56K | Form 4 |
| Sep 1, 2026 | Klein Lawrence OttoChief Executive Officer | Option exercise | 75,000 | $585.00K | Form 4 |
| Sep 1, 2026 | Sandler Laura LeeChief Operating Officer | Sale | 4,000 | $368.05K | Form 4 |
| Sep 1, 2026 | Sandler Laura LeeChief Operating Officer | Sale | 1,000 | $91.05K | Form 4 |
| Sep 1, 2026 | Sandler Laura LeeChief Operating Officer | Option exercise | 5,000 | $39.00K | Form 4 |
| Aug 24, 2026 | Edwards Larry ToddChief Commercial Officer | Award | 100,000 | — | Form 4 |
| Aug 17, 2026 | Goncalves JoanaChief Medical Officer | Sale | 2,480 | $279.15K | Form 4 |
| Aug 17, 2026 | Goncalves JoanaChief Medical Officer | Sale | 3,320 | $371.89K | Form 4 |
| Aug 17, 2026 | Goncalves JoanaChief Medical Officer | Sale | 300 | $33.16K | Form 4 |
| Aug 17, 2026 | Goncalves JoanaChief Medical Officer | Sale | 900 | $98.69K | Form 4 |
| Aug 17, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $27.30K | Form 4 |
| Aug 17, 2026 | Goncalves JoanaChief Medical Officer | Option exercise | 3,500 | $23.94K | Form 4 |
| Aug 14, 2026 | Quinlan Paul TGeneral Counsel | Sale | 10,200 | $1.11M | Form 4 |
| Aug 14, 2026 | Quinlan Paul TGeneral Counsel | Sale | 14,696 | $1.59M | Form 4 |
| Aug 14, 2026 | Quinlan Paul TGeneral Counsel | Sale | 10,434 | $1.12M | Form 4 |
| Aug 14, 2026 | Quinlan Paul TGeneral Counsel | Sale | 3,630 | $384.96K | Form 4 |
| Aug 14, 2026 | Quinlan Paul TGeneral Counsel | Option exercise | 42,000 | $525.00K | Form 4 |
| Aug 14, 2026 | Quinlan Paul TGeneral Counsel | Option exercise | 10,000 | $78.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4